Kimberly-Clark Corporatio... (KMB)
NYSE: KMB
· Real-Time Price · USD
143.76
-0.08 (-0.06%)
At close: May 30, 2025, 3:59 PM
143.29
-0.33%
After-hours: May 30, 2025, 05:21 PM EDT
Kimberly-Clark Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumer Tissue Revenue | 6.16B | 6.29B | 6.24B | 6.03B | 6.72B | 5.99B | 6.01B | 5.93B | 5.97B | 6.12B | 6.64B | 6.64B | 6.53B | 6.7B | 6.4B |
| Consumer Tissue Revenue Growth | -2.11% | +0.75% | +3.46% | -10.18% | +12.10% | -0.37% | +1.40% | -0.59% | -2.52% | -7.89% | +0.12% | +1.69% | -2.58% | +4.69% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States Revenue | 10.4B | 10.36B | 9.85B | 9.29B | 9.68B | 9.03B | 8.8B | 8.7B | 8.87B | 8.82B | 8.57B | 9.78B | 10.51B | 10.46B | 10.48B |
| United States Revenue Growth | +0.37% | +5.22% | +6.06% | -4.07% | +7.22% | +2.54% | +1.21% | -1.98% | +0.62% | +2.87% | -12.37% | -6.93% | +0.47% | -0.16% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 941M | 1.11B | 1.1B | 1.07B | 1.04B | 993M | 1.03B | 1.01B | 924M | 916M | 873M | 906M | 886M | 911M | 819M | 854M | 815M | 996M | 919M | 844M | 873M | 859M | 815M | 811M | 769M | 768M | 749M | 771M | 1.08B | 759M | 813M | 842M | 813M | 821M | 833M | 847M | 825M | 857M | 868M | 869M | 849M |
| Selling, General, and Administrative Revenue Growth | -15.15% | +1.09% | +2.91% | +2.60% | +4.63% | -3.50% | +1.38% | +9.85% | +0.87% | +4.93% | -3.64% | +2.26% | -2.74% | +11.23% | -4.10% | +4.79% | -18.17% | +8.38% | +8.89% | -3.32% | +1.63% | +5.40% | +0.49% | +5.46% | +0.13% | +2.54% | -2.85% | -28.54% | +42.16% | -6.64% | -3.44% | +3.57% | -0.97% | -1.44% | -1.65% | +2.67% | -3.73% | -1.27% | -0.12% | +2.36% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | 312M | n/a | n/a | n/a | 292M | n/a | n/a | n/a | 269M | n/a | n/a | n/a | 276M | n/a | n/a | n/a | 284M | n/a | n/a | n/a | 317M | n/a | n/a | n/a | 309M | n/a | n/a | n/a | 328M | n/a | n/a | n/a | 324M | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |